The Interplay between Cannabinoid Receptors and Microglia in the Pathophysiology of Alzheimer’s Disease
Journal of Clinical Medicine · 21.11.2023 · 12 (23) · 7201
DOI: 10.3390/jcm12237201 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 21.11.2023. Verfasst von Rebecca Ferrisi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University of Pisa, 56126 Pisa, Italy. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is characterized by massive neuronal death, brain atrophy, and loss of neurons and synapses, which all lead to a progressive cognitive decline. Neuroinflammation has been recently identified as one of the main causes of AD progression, and microglia cells are considered to have a central role in this process. Growing evidence suggests that cannabinoids may be used as preventive treatment for AD. An altered expression of the endocannabinoids (eCBs) and their receptors (CBRs) is reported in several neurodegenerative disorders, including AD. Moreover, the modulation of CBRs demonstrated neuroprotective effects in reducing aggregated protein deposition, suggesting the therapeutic potential of natural and synthetic CBR ligands in the treatment of neurodegenerative proteinopathies. Here, we review the current knowledge regarding the involvement of CBRs in the modulation of microglia activation phenotypes, highlighting the role of neuroinflammation in the pathogenesis of neurodegenerative diseases, like AD. We also provide an overview of recently developed candidate drugs targeting CBRs that may afford a new innovative strategy for the treatment and management of AD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, University of Pisa, 56126 Pisa, Italy.
- Department of Pharmaceutical Sciences, University of Milan, 20133 Milano, Italy.
- Department of Pathology, University of Pisa, 56126 Pisa, Italy.
ORCID-Profile: Rebecca Ferrisi, Beatrice Polini, Grazia Chiellini
Zitieren
APA
Ferrisi, R., Gado, F., Ricardi, C., Polini, B., Manera, C., & Chiellini, G. (2023). The Interplay between Cannabinoid Receptors and Microglia in the Pathophysiology of Alzheimer’s Disease. Journal of Clinical Medicine, 12(23), 7201. https://doi.org/10.3390/jcm12237201
Vancouver
Ferrisi R, Gado F, Ricardi C, Polini B, Manera C, Chiellini G. The Interplay between Cannabinoid Receptors and Microglia in the Pathophysiology of Alzheimer’s Disease. Journal of Clinical Medicine. 2023;12(23):7201. doi:10.3390/jcm12237201
BibTeX
@article{Ferrisi2023,
author = {Ferrisi, Rebecca and Gado, Francesca and Ricardi, Caterina and Polini, Beatrice and Manera, Clementina and Chiellini, Grazia},
title = {The Interplay between Cannabinoid Receptors and Microglia in the Pathophysiology of Alzheimer’s Disease},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {23},
pages = {7201},
doi = {10.3390/jcm12237201}
}
EUVIMED